Merck appoints Bridgette Heller
pharmafile | March 5, 2010 | Appointment | Sales and Marketing | Merck, appointment, consumer healthcare, sales and marketing
Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care.
She moves to Merck from Johnson & Johnson, where she had served as president of that company’s global baby business since 2007.
Prior to that she was Johnson & Johnson’s global president, baby, kids and wound care.
In her new role Heller will leverage Merck’s consumer products brands to capitalise on new growth opportunities, including expanding the consumer business in markets outside the US.
Merck’s consumer products include nasal congestion spray Afrin, allergy treatment Claritin and Lotrimin for athletes foot.
Related Content
TILT Biotherapeutics shares data on TILT-123 with Keytruda for ovarian cancer treatment
TILT Biotherapeutics has announced promising preliminary safety and efficacy data from its ongoing phase 1 …
FDA approves Merck’s Winrevair for PAH treatment
Merck, known as MSD outside of the US and Canada, has announced that the US …
Merck shares results for Keytruda in cervical cancer treatment
Merck, known as MSD outside of the US and Canada, has announced positive results from …